Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
4
×
amgen
eli lilly
fda
new york blog main
boston blog main
boston top stories
calcitonin gene-related peptide
chronic migraine
episodic migraine
indiana blog main
indiana top stories
migraine
national
national top stories
teva pharmaceutical
abbvie
alder biopharmaceuticals
allergan
biohaven
boston
boulder/denver blog main
boulder/denver top stories
cancer
cgpr
codiak biosciences
cutaneous t-cell lymphoma
david rind
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe blog main
exosome
food and drug administration
fremanezumab
What
class
4
×
medicines
4
×
new
fda
migraine
approval
approved
developed
drug
nod
pain
starts
won
adults
allergan
amgen
announced
based
begin
biosciences
bio’s
brings
bubbles
candidates
cells
clinical
codiak
decision
eli
exosome
exosomes
formed
fund
gets
head
headache
ipo
late
lilly
marks
Language
unset
Current search:
" national blog main "
×
medicines
×
class
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines